FDA Brief

Warning letters Devices

FDA warning letter to

Flux Lab Pte. Ltd. d/b/a The Fluxion

MediumIssued Dec 16, 2025Posted Dec 18, 2025Center for Devices and Radiological Health

FDA warns Flux Lab/The Fluxion over unregistered, unlisted chest binders marketed as medical devices.

What happened

FDA reviewed the website thefluxion.com and found breast binders offered for sale with statements that binding can alleviate gender dysphoria and affect the body, making them devices. FDA also said the company manufactures these devices and its records show no registration or listing for fiscal year 2026.

What FDA found

  1. FDA says the chest binders are medical devices because the website claims they alleviate gender dysphoria or affect body structure or function.

    section 201(h) of the Act, 21 U.S.C. § 321(h)
  2. FDA says the company did not register as a device manufacturer for fiscal year 2026 as required.

    section 510 of the Act, 21 U.S.C. § 360; section 510(p), 21 U.S.C. § 360(p)
  3. FDA says the company did not list the devices with FDA as required.

    section 510(j) of the Act, 21 U.S.C. § 360(j)
  4. FDA says the devices are misbranded (not properly registered or listed) because they were made in an establishment not duly registered and were not included in a required device list.

    section 502(o) of the Act, 21 U.S.C. § 352(o)

What FDA wants

FDA asks the company to respond in writing within 15 business days with the specific steps taken, how it will prevent repeat violations, and documentation of corrections or corrective actions, plus a timetable if more time is needed. If the company believes it is not in violation, FDA asks for its reasoning and supporting information.

Who should pay attention

  • foreign device manufacturers selling to U.S. consumers
  • online sellers of chest binders or compression garments with health claims
  • regulatory teams responsible for FDA registration and listing

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Skytron, LLC

    Skytron marketed four UV disinfection devices without FDA clearance or approval and kept unapproved medical claims after promising to remove them.

    High risk
  2. TG Supply LLC d/b/a TransGuy Supply

    FDA warned TransGuy Supply that its breast binders are unregistered, unlisted medical devices.

    Low
  3. Marli Washington Design, LLC

    Marli Washington Design (gc2b) sold breast binders as medical devices without FDA registration or listing for FY2026, making them misbranded.

    Low
  4. FLAVNT Streetwear, LLC

    FDA says FLAVNT Streetwear sold breast binders as medical devices without registering or listing them for fiscal 2026.

    Low